Published in J Immunol on September 01, 1956
Interaction of the rheumatoid factor with antigen-antibody complexes and aggregated gamma globulin. J Exp Med (1958) 7.85
An unusual protein component of high molecular weight in the serum of certain patients with rheumatoid arthritis. J Exp Med (1957) 5.79
Characterization of the reactant (gamma globulin factor) in the F II precipitin reaction and the F II tanned sheep cell agglutination test. J Exp Med (1958) 3.57
The induction of a rheumatoid factor-like substance in rabbits. J Exp Med (1961) 3.33
Specificity of the reaction between rheumatoid factors and gamma globulin. J Exp Med (1961) 2.43
Studies on the isolation and characterization of the "rheumatoid factor". J Clin Invest (1959) 2.38
Rheumatoid factor in synovial effusions: local production and consumption. Clin Exp Immunol (1967) 1.69
Serum opsonin, bacteria, and polymorphonuclear leukocyte interactions in subacute bacterial endocarditis. Anti-gamma-globulin factors and their interaction with specific opsonins. J Clin Invest (1968) 1.53
THE REACTION OF RHEUMATOID FACTOR WITH ANIMAL GAMMA-GLOBULINS: QUANTITATIVE CONSIDERATIONS. Immunology (1965) 1.42
Haemolytic complement level and ragocyte (R A cell) concentration in synovial fluid. Ann Rheum Dis (1967) 1.00
Interactions of rheumatoid factor with immune precipitate containing antibody of human origin. Ann Rheum Dis (1961) 0.88
Role of hypersensitivity in the pathogenesis of rheumatoid arthritis. Ann Rheum Dis (1959) 0.85
Immunoglobulin synthesis by human peripheral lymphocytes and thymocytes in vitro. Specificity of immunochemical methods and stimulation by phytohaemagglutinin. Clin Exp Immunol (1969) 0.80
Beyond citrullination: other post-translational protein modifications in rheumatoid arthritis. Nat Rev Rheumatol (2017) 0.78
Historical observations contributing insights on etiopathogenesis of rheumatoid arthritis and role of rheumatoid factor. J Exp Med (2016) 0.77
Antinuclear factors in rheumatoid arthritis. Increasing organ-non-specificity with increasing reactivity of rheumatoid factor with heterologous gamma globulin. Ann Rheum Dis (1968) 0.75
Discussion on rheumatoid disease: the clinical aspect. Proc R Soc Med (1957) 0.75
Reactivity between rheumatoid factor and rheumatoid tissue. Ann Rheum Dis (1971) 0.75
In vitro cell migration as a model for delayed hypersensitivity. Proc Soc Exp Biol Med (1962) 11.91
Use of anti-Rh sera for demonstrating agglutination activating factor in rheumatoid arthritis. Proc Soc Exp Biol Med (1956) 3.61
GAMMA-2, GAMMA-1A AND GAMMA-1M ANTINUCLEAR FACTORS IN HUMAN SERA. J Clin Invest (1964) 2.17
Serum responses in rheumatoid arthritis. Am J Med (1959) 2.01
The effect of 5-bromouracil deoxyriboside on the synthesis of antibody in vitro. Biochem J (1960) 1.76
Serum complement in rheumatoid arthritis. Am J Med Sci (1951) 1.51
Quantitative considerations of the rheumatoid factor. J Immunol (1958) 1.50
THE REACTION OF RHEUMATOID FACTOR WITH ANIMAL GAMMA-GLOBULINS: QUANTITATIVE CONSIDERATIONS. Immunology (1965) 1.42
A study of antibody production in vitro. J Immunol (1960) 1.40
HEMAGGLUTINATION BY RHEUMATOID FACTOR OF CELLS COATED WITH ANIMAL GAMMA GLOBULINS. Proc Soc Exp Biol Med (1964) 1.39
The response of serum gamma globulin level and complement titer to adrenocorticotropic hormone therapy in lupus erythematosus disseminatus. J Lab Clin Med (1951) 1.34
A study of gamma globulin in rheumatoid arthritis. J Clin Invest (1955) 1.20
Effect of 17-hydroxy-11-dehydrocorticosterone and adrenocorticotropic hormone upon plasma gamma globulin, fibrinogen, and erythrocyte sedimentation rate. Proc Soc Exp Biol Med (1951) 1.20
HETEROGENEITY OF ANTINUCLEAR FACTORS IN LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS. Proc Soc Exp Biol Med (1965) 1.18
Transfusion studies in rheumatoid arthritis. Arthritis Rheum (1961) 1.15
Current status of the rheumatoid factor. Ann Intern Med (1962) 1.08
IMMUNOLOGIC RESPONSIVENESS OF MAN TO PENICILLIN. JAMA (1963) 1.04
Partition of the skin-sensitizing antibody among alcohol-fractionated plasma proteins. J Allergy (1952) 1.04
Studies on the antibodies in rabbit antisera responsible for sensitization of human skin. II. Characteristics of antisera to egg white and to conalbumin. J Allergy (1954) 1.03
Inhibition of rapid production of antibody by cortisone; study of secondary response. Proc Soc Exp Biol Med (1952) 1.00
The effect of ACTH on blood complement, gamma globulins, and fibrinogen. J Clin Invest (1950) 0.99
Observations on the nature of the antigen in tanned red cell hemagglutination. J Immunol (1962) 0.98
ANTINUCLEAR FACTORS IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS. Ann Intern Med (1965) 0.97
The unitary nature of "complete" and "incomplete" pathologic cold hemagglutinins. Blood (1962) 0.96
CALCINOSIS UNIVERSALIS COMPLICATING DERMATOMYOSITIS. ITS TREATMENT WITH NA2 EDTA. REPORT OF TWO CASES IN CHILDREN. Arthritis Rheum (1964) 0.96
The role of complement in the lysis of leucocytes by tuberculo-protein. Proc Soc Exp Biol Med (1949) 0.94
Immunologic features of erythrocyte sensitization. I. Acquired hemolytic disease. Blood (1956) 0.91
Immunologic features of erythrocyte sensitization. II. The nature of blood group antibodies. Blood (1957) 0.89
Immunologic reactions to penicillin. J Allergy (1961) 0.88
SERUM SICKNESS AND PLASMACYTOSIS. A CLINICAL, IMMUNOLOGIC AND HEMATOLOGIC ANALYSIS. Am J Med (1963) 0.86
Eosinophiles in passive anaphylaxis. Proc Soc Exp Biol Med (1955) 0.85
DYSGAMMAGLOBULINEMIA IN THE PRESENCE OF PLASMA CELLS. N Engl J Med (1965) 0.83
AUTO-SENSITIZATION OF TRYPSIN TREATED HUMAN RED CELLS BY COMPLEMENT. Proc Soc Exp Biol Med (1964) 0.82
SPECIFICITY OF RHEUMATOID FACTOR WITH GAMMA GLOBULIN OF DIFFERENT SPECIES. Arthritis Rheum (1963) 0.81
The rheumatoid factor activity of dextran eluates of erythrocytes and platelets. Arthritis Rheum (1963) 0.79
An unidentified antibody in anti-egg albumin sera revealed by the agar diffusion technic; methods for its immunochemical analysis. J Immunol (1954) 0.78
Relation of agammaglobulinemia sera to rheumatoid agglutination reactions. Arthritis Rheum (1958) 0.76
Immunochemical nature of anti red cell antibodies. Bibl Haematol (1958) 0.75
Hypersensitivity in the rheumatic diseases. Med Clin North Am (1961) 0.75
Thirty years experience with radiation therapy of pharyngeal lymphoid tissue. Eye Ear Nose Throat Mon (1956) 0.75
Contact x-ray therapy. Miss Valley Med J (1951) 0.75
Treatment of infected tonsils and adenoids. Clin Med (Northfield) (1949) 0.75
Problems in the corticosteroid therapy of rheumatic disease. Ann Intern Med (1959) 0.75
Systemic lupus erythematosus an increasing problem; a clinical survey of 35 cases. Va Med Mon (1918) (1958) 0.75
Effect of an anabolic agent (nilevar) on nitrogen and mineral metabolism in two patients with rheumatoid disease. Arthritis Rheum (1960) 0.75
EVALUATION OF A NEW VASOPRESSOR AGENT. ANGIOTENSIN AMIDE. JAMA (1963) 0.75
Agglutination by rheumatoid sera of red cells coated with non-agglutinating anti-D antibody. Bibl Haematol (1958) 0.75
Nephrocalcinosis. Am J Roentgenol Radium Ther (1947) 0.75
RHEUMATIC DISEASES IN THE USSR. Bull Rheum Dis (1965) 0.75
Phosphate metabolism of spleen cells in antibody formation. J Immunol (1960) 0.75
The eighth (1961) interim scientific session of the American Rheumatism Association. Bull Rheum Dis (1962) 0.75
Radiation treatment of infected or hypertrophied lymphoid tissue in the throat and nasopharynx. Med Times (1947) 0.75